InSimili recreates the real human body microenvironment in vitro, enabling better decisions in pre-clinical studies and reducing in vivo testing.​ Helping develop new therapies more efficiently and safely.

Cells experience different oxygen availability in the body. Our technology regulates the concentration of oxygen and other agents at the microscale. Mimicking unique conditions found in patients in a standard consumable.

Our patented solution maintains a stable chemical microenvironment from cell culturing to imaging. It is standard compliant, cost-effective, and scalable. Unlocking the potential of testing in hypoxic conditions from high throughput screening to complex 3D models.

InSimili started in 2021 as a spin-off of the University of Bologna. Its proprietary technology was invented by professor Stefania Rapino group, and already used in prominent Italian research institutes.